Skip to main content
WorldVoice 360
PoliticsNorth America

Trump's Tariff Threat on Denmark: Implications for Popular Products

President-elect's proposed tariffs could impact access to Danish-made medicines and goods in the U.S.

By Ana Swanson and Jenny GrossSource: nytimes.com1 min read
Trump's Tariff Threat on Denmark: Implications for Popular Products
Image via nytimes.com

In brief

Trump's new tariff strategy could affect the availability and pricing of essential products, including weight-loss drugs like Ozempic, imported from Denmark.

President-elect Donald J. Trump recently intensified his campaign rhetoric regarding tariffs, now singling out Denmark with a warning of "very high" tariffs unless the country agrees to cede Greenland to the United States. Trump asserted the significance of Greenland to national security, despite Denmark being a relatively minor trade partner for the U.S. with its exports totaling over $11 billion in 2023. The proposed tariffs could have ripple effects on various beloved products widely consumed by Americans. Notably, a substantial portion of Danish exports to the U.S. comprises packaged medicines, including vaccines and insulin, primarily manufactured by Novo Nordisk, a key player in the Danish economy known for its weight-loss drugs Ozempic and Wegovy. According to trade experts, nearly half of Denmark's exports to the U.S. consist of these essential medicines. Novo Nordisk has increased U.S. production to meet soaring demand for its GLP-1 weight-loss products, with a spokesperson highlighting their close monitoring of the situation but refraining from commenting on potential tariff impacts. If tariffs are enacted, the prices for these popular medications could rise significantly, constituting a serious concern for consumers who rely on these products for their health and well-being.

Topics

More on this story